These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 26297026)
1. Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors. Garwood CJ; Ratcliffe LE; Morgan SV; Simpson JE; Owens H; Vazquez-Villaseñor I; Heath PR; Romero IA; Ince PG; Wharton SB Mol Brain; 2015 Aug; 8():51. PubMed ID: 26297026 [TBL] [Abstract][Full Text] [Related]
2. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2. Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910 [TBL] [Abstract][Full Text] [Related]
3. A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression. Chrudinová M; Kirk NS; Chuard A; Venugopal H; Zhang F; Lubos M; Gelfanov V; Páníková T; Žáková L; Cutone J; Mojares M; DiMarchi R; Jiráček J; Altindis E Mol Metab; 2024 Feb; 80():101863. PubMed ID: 38182007 [TBL] [Abstract][Full Text] [Related]
4. Novel nuclear localization and potential function of insulin-like growth factor-1 receptor/insulin receptor hybrid in corneal epithelial cells. Wu YC; Zhu M; Robertson DM PLoS One; 2012; 7(8):e42483. PubMed ID: 22879999 [TBL] [Abstract][Full Text] [Related]
5. Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor. Vincent EE; Elder DJ; Curwen J; Kilgour E; Hers I; Tavaré JM PLoS One; 2013; 8(6):e66963. PubMed ID: 23826179 [TBL] [Abstract][Full Text] [Related]
9. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Moloney AM; Griffin RJ; Timmons S; O'Connor R; Ravid R; O'Neill C Neurobiol Aging; 2010 Feb; 31(2):224-43. PubMed ID: 18479783 [TBL] [Abstract][Full Text] [Related]
10. Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Sciacca L; Cassarino MF; Genua M; Pandini G; Le Moli R; Squatrito S; Vigneri R Diabetologia; 2010 Aug; 53(8):1743-53. PubMed ID: 20424816 [TBL] [Abstract][Full Text] [Related]
11. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia. Zemva J; Schubert M Curr Diabetes Rev; 2011 Sep; 7(5):356-66. PubMed ID: 21916834 [TBL] [Abstract][Full Text] [Related]
12. Insulin and IGF1 receptors in human cardiac microvascular endothelial cells: metabolic, mitogenic and anti-inflammatory effects. Bäck K; Islam R; Johansson GS; Chisalita SI; Arnqvist HJ J Endocrinol; 2012 Oct; 215(1):89-96. PubMed ID: 22825921 [TBL] [Abstract][Full Text] [Related]
13. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer. Buck E; Gokhale PC; Koujak S; Brown E; Eyzaguirre A; Tao N; Rosenfeld-Franklin M; Lerner L; Chiu MI; Wild R; Epstein D; Pachter JA; Miglarese MR Mol Cancer Ther; 2010 Oct; 9(10):2652-64. PubMed ID: 20924128 [TBL] [Abstract][Full Text] [Related]
14. Human microvascular endothelial cells are sensitive to IGF-I but resistant to insulin at the receptor level. Johansson GS; Chisalita SI; Arnqvist HJ Mol Cell Endocrinol; 2008 Dec; 296(1-2):58-63. PubMed ID: 18708119 [TBL] [Abstract][Full Text] [Related]
15. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling. Varewijck AJ; Brugts MP; Frystyk J; Goudzwaard JA; Uitterlinden P; Waaijers AM; Feng Y; Dimitrov DS; Lamberts SW; Hofland LJ; Janssen JA Mol Cell Endocrinol; 2013 Jan; 365(1):17-24. PubMed ID: 22982059 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like modulation of Akt/FoxO signaling by copper ions is independent of insulin receptor. Hamann I; Petroll K; Grimm L; Hartwig A; Klotz LO Arch Biochem Biophys; 2014 Sep; 558():42-50. PubMed ID: 24933099 [TBL] [Abstract][Full Text] [Related]
17. Insulin receptor (IR) pathway hyperactivity in IGF-IR null cells and suppression of downstream growth signaling using the dual IGF-IR/IR inhibitor, BMS-754807. Dinchuk JE; Cao C; Huang F; Reeves KA; Wang J; Myers F; Cantor GH; Zhou X; Attar RM; Gottardis M; Carboni JM Endocrinology; 2010 Sep; 151(9):4123-32. PubMed ID: 20610571 [TBL] [Abstract][Full Text] [Related]
18. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation. Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554 [TBL] [Abstract][Full Text] [Related]
19. Extracellular vimentin interacts with insulin-like growth factor 1 receptor to promote axonal growth. Shigyo M; Kuboyama T; Sawai Y; Tada-Umezaki M; Tohda C Sci Rep; 2015 Jul; 5():12055. PubMed ID: 26170015 [TBL] [Abstract][Full Text] [Related]
20. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells. Sarfstein R; Nagaraj K; LeRoith D; Werner H Cells; 2019 Nov; 8(12):. PubMed ID: 31771180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]